MedTrace Logo

The Effects of Physical Training, ASA (Aspirin), and Clopidogrel on the Walking Capacity of Patients With Stage II Peripheral Arterial Disease (PAD)

NCT00189618 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2008-10-06

No results posted yet for this study

Summary

To evaluate the change in walking capacity after a well organized and structured intensive physical training program with supportive pharmacotherapy with Clopidogrel or ASA. It is hypothesized that statistically superior results will emerge from a structured training supported by Clopidogrel as compared to a structured training supported by ASA.

Conditions

  • Peripheral Arterial Disease

Interventions

DRUG

Aspirin

100mg p.o. OD

DRUG

Clopidogrel

75mg p.o. OD

Sponsors & Collaborators

  • Arteriogenesis Competence Network

    lead OTHER

Principal Investigators

  • Kurt A Jaeger, MD, Prof · University Hospital, Basel, Switzerland

  • Ulrich Hoffmann, MD, Prof · University Hospital Munich (LMU)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-05-31
Primary Completion
2008-04-30
Completion
2008-06-30

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00189618 on ClinicalTrials.gov